Skip to main content
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: J Neurochem. 2010 Mar 31;114(1):51–61. doi: 10.1111/j.1471-4159.2010.06721.x

Fig. 2.

Fig. 2

Binding efficiency of ligands to D2DR and D1DR in MsrA−/− and WT membranes. Specific ligand binding was calculated from subtracting non-specific ligand binding from total ligand binding as described in ‘Materials and Methods’. (a) Representative [3H]raclopride and [3H]quinpirole specific ligand binding curves of D2DR. (b) Bmax of [3H]quinpirole binding presented as percent of WT Bmax value (represents 100% binding) in the absence (Control) and presence of recombinant yeast MsrA (rMsrA Added). (c) Binding of [3H]SCH23390 at a saturating concentration (Bmax value WT, under these conditions, represents 100% binding). (d) Relative binding of [3H]SCH23390 at a concentration of 2 nM (as in panel c) in the presence of 2 nM and 16 nM SKF82958 concentrations. For all graphs, n = 3. Significance is denoted by * or indicating p < 0.05 using t-test for difference by mouse type or by condition, respectively.